- Home
- TLIH vs COEP Comparison
TLIH vs COEP Comparison
Compare TLIH & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLIH
- COEP
- Stock Information
- Founded
- TLIH 1998
- COEP 2017
- Country
- TLIH Singapore
- COEP United States
- Employees
- TLIH N/A
- COEP N/A
- Industry
- TLIH
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TLIH
- COEP Health Care
- Exchange
- TLIH Nasdaq
- COEP Nasdaq
- Market Cap
- TLIH 29.1M
- COEP 65.8M
- IPO Year
- TLIH 2025
- COEP N/A
- Fundamental
- Price
- TLIH $0.55
- COEP $13.49
- Analyst Decision
- TLIH
- COEP
- Analyst Count
- TLIH 0
- COEP 0
- Target Price
- TLIH N/A
- COEP N/A
- AVG Volume (30 Days)
- TLIH 393.7K
- COEP 46.8K
- Earning Date
- TLIH 01-01-0001
- COEP 08-14-2025
- Dividend Yield
- TLIH N/A
- COEP N/A
- EPS Growth
- TLIH N/A
- COEP N/A
- EPS
- TLIH 0.05
- COEP N/A
- Revenue
- TLIH $42,862,063.00
- COEP $263,555.00
- Revenue This Year
- TLIH N/A
- COEP N/A
- Revenue Next Year
- TLIH N/A
- COEP N/A
- P/E Ratio
- TLIH $11.07
- COEP N/A
- Revenue Growth
- TLIH N/A
- COEP N/A
- 52 Week Low
- TLIH $0.53
- COEP $2.31
- 52 Week High
- TLIH $7.00
- COEP $14.70
- Technical
- Relative Strength Index (RSI)
- TLIH N/A
- COEP 60.14
- Support Level
- TLIH N/A
- COEP $12.50
- Resistance Level
- TLIH N/A
- COEP $14.09
- Average True Range (ATR)
- TLIH 0.00
- COEP 0.99
- MACD
- TLIH 0.00
- COEP -0.05
- Stochastic Oscillator
- TLIH 0.00
- COEP 68.95
About TLIH Ten-League International Holdings Limited Ordinary Shares
Ten-League International Holdings Ltd is a Singapore-based provider of turnkey project solutions. Its business consists of sales of heavy equipment and parts, heavy equipment rental and provision of engineering consultancy services to port, construction, civil engineering and underground foundation industries. It currently conducts its operations through its wholly-owned subsidiaries. The equipment it provides is organized into four categories based on their functions and application scenarios, namely, foundation equipment, hoist equipment, excavation equipment and port machinery. The company operates in Singapore and Other International Countries.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.